top of page
.png)
20,000+ Microbiome Sample Database
4,000+ Ingredient Database
10,000+ Testing Participants Globally
60+ Industry
Partners
Who We Are
Sequential is the industry leader in clinical microbiome research and testing offering a comprehensive end-to-end platform designed to bring science backed solutions to the personal care and pharma industry. We are a team of award-winning scientists who’s aim is to understand the impact of the microbiome on the host (humans) and how the host impacts the microbiome in order to fully characterise human health.
What We Offer
A fully customizable microbiome study to test your product's impact in a real-life context.
Allow our formulation experts to guide you through the process of creating a product that maintains the biome.
Test your formulation to understand what marketing claims you can attribute to your product.
Join us in full end-to-end partnership (testing to collaborating on white papers).
Understand your product's impact on transepidermal water loss, pH, and elasticity.
Let us recruit candidates and carry out in-lab testing for your study to ensure controlled collection.
Our Testing Capabilities
Differentiate your brand by harnessing the power of skin microbiome science. Stand out from competitors with products backed by robust research and gold standard certification that resonates with customers seeking credible, innovative personal care offerings.
What Our Clients Say
FAQ
-
What is Sequential's testing platform?Sequential has developed the gold standard test for microbiome-friendly products, in vivo (in, or on, humans). Finally, we can give some certainty about if a product is truly affecting the microbiome. We offer a complete end-to-end solution to support microbiome-friendly claims. From consultancy and study design to our proprietary microbiome testing kits. We analyse, interpret and report our findings to meet your needs.
-
Why is it necessary to test the microbiome in vivo?At present, there are no regulations for microbiome-related formulas that brands and formulators can follow, however, it has been universally acknowledged that the in vivo method of conducting clinical studies is becoming critical and paramount to getting marketing claims through. When regulations are introduced, which may be imminent, the in vitro system will find itself lacking, resulting in limited claims and certifications that do not hold their value. This is why, we at Sequential strive to offer an in vivo approach, knowing full well that we want our client's claims to be significantly backed by scientific and quantifiable data.
-
What type of sequencing technology does Sequential use for analysis?We offer four types of sequencing techniques including qPCR with our Smart Probes™, 16S, ITS and Shotgun Metagenomics. Using next-generation sequencing of the collection of microorganisms found on the body, during product usage, Sequential investigates the microbial diversity, and particular microorganisms we know are important and play a role in a healthy microbiome.
-
Does Sequential offer claims certification for tested products?We provide our clients with a certification to claim “Maintains the Microbiome” subject to in vivo testing results which can be used in communication efforts. Once your product is tested with our qPCR Smart Probes™ and has shown favourable results in supporting the microbiome, we can certify your product with our Maintains the Microbiome certification seal. We have ensured that our seal and certification are backed by quantifiable data and scientifically significant markers. The aim is to ensure our clients feel confident in making their claims and can communicate the true benefit of their microbiome formulations.
bottom of page